Marcel Kloosterman

Managing Partner

2021

Director

2016 - 2021

Director

2021

- settlement of promissing start-up companies (LifeSciences, Performance Materials) to the Chemelot site (DSM, Sabic, Sekisui) at Geleen (NL) using equity financing. If needed, the financing round may be expanded by raising a consortium of investors, combined with attracting provincial subsidies and innovative credit facilities supplied by the State

Director

2016

Investment manager

2010 - 2016

Senior Associate

2002 - 2010

- financing of private companies that have high synergy with DSM's business groups and emerging business areas. Using a venture capital approach, while maximising mutually beneficial links (license, R&D/M&S collaboration, production) between private companies and DSM. Fund size Euro 200 Mln, with size of investments 0.5 - 10 Mln.

Investment Manager

2010 - 2011

Manager New Business Development

2000 - 2004

Business Development manager

Manager Emerging Technologies

1998 - 1999

Corporate Secretary

1995 - 1998

Manager Marketing Research

1990 - 1995

Project manager

1985 - 1989